Pharmacokinetics of Alternative Administration Routes of Melatonin: A Systematic Review

Research output: Contribution to journalReviewResearchpeer-review

Standard

Pharmacokinetics of Alternative Administration Routes of Melatonin : A Systematic Review. / Zetner, D.; Andersen, L. P.H.; Rosenberg, J.

In: Drug Research, Vol. 66, No. 4, 2016, p. 169-173.

Research output: Contribution to journalReviewResearchpeer-review

Harvard

Zetner, D, Andersen, LPH & Rosenberg, J 2016, 'Pharmacokinetics of Alternative Administration Routes of Melatonin: A Systematic Review', Drug Research, vol. 66, no. 4, pp. 169-173. https://doi.org/10.1055/s-0035-1565083

APA

Zetner, D., Andersen, L. P. H., & Rosenberg, J. (2016). Pharmacokinetics of Alternative Administration Routes of Melatonin: A Systematic Review. Drug Research, 66(4), 169-173. https://doi.org/10.1055/s-0035-1565083

Vancouver

Zetner D, Andersen LPH, Rosenberg J. Pharmacokinetics of Alternative Administration Routes of Melatonin: A Systematic Review. Drug Research. 2016;66(4):169-173. https://doi.org/10.1055/s-0035-1565083

Author

Zetner, D. ; Andersen, L. P.H. ; Rosenberg, J. / Pharmacokinetics of Alternative Administration Routes of Melatonin : A Systematic Review. In: Drug Research. 2016 ; Vol. 66, No. 4. pp. 169-173.

Bibtex

@article{c04e65f9c3a6465484482219aa25821b,
title = "Pharmacokinetics of Alternative Administration Routes of Melatonin: A Systematic Review",
abstract = "Background: Melatonin is traditionally administered orally but has a poor and variable bioavailability. This study aims to present an overview of studies investigating the pharmacokinetics of alternative administration routes of melatonin. Methods: A systematic literature search was performed and included experimental or clinical studies, investigating pharmacokinetics of alternative administration routes of melatonin in vivo. Alternative administration routes were defined as all administration routes except oral and intravenous. Results: 10 studies were included in the review. Intranasal administration exhibited a quick absorption rate and high bioavailability. Transdermal administration displayed a variable absorption rate and possible deposition of melatonin in the skin. Oral transmucosal administration of melatonin exhibited a high plasma concentration compared to oral administration. Subcutaneous injection of melatonin displayed a rapid absorption rate compared to oral administration. Conclusion: Intranasal administration of melatonin has a large potential, and more research in humans is warranted. Transdermal application of melatonin has a possible use in a local application, due to slow absorption and deposition in the skin. Oral transmucosal administration may potentially be a clinically relevant due to avoiding first-pass metabolism. Subcutaneous injection of melatonin did not document any advantages compared to other administration routes.",
keywords = "bioavailability, intranasal, subcutaneous, transdermal, transmucosal",
author = "D. Zetner and Andersen, {L. P.H.} and J. Rosenberg",
year = "2016",
doi = "10.1055/s-0035-1565083",
language = "English",
volume = "66",
pages = "169--173",
journal = "Drug Research",
issn = "2194-9379",
publisher = "GeorgThieme Verlag",
number = "4",

}

RIS

TY - JOUR

T1 - Pharmacokinetics of Alternative Administration Routes of Melatonin

T2 - A Systematic Review

AU - Zetner, D.

AU - Andersen, L. P.H.

AU - Rosenberg, J.

PY - 2016

Y1 - 2016

N2 - Background: Melatonin is traditionally administered orally but has a poor and variable bioavailability. This study aims to present an overview of studies investigating the pharmacokinetics of alternative administration routes of melatonin. Methods: A systematic literature search was performed and included experimental or clinical studies, investigating pharmacokinetics of alternative administration routes of melatonin in vivo. Alternative administration routes were defined as all administration routes except oral and intravenous. Results: 10 studies were included in the review. Intranasal administration exhibited a quick absorption rate and high bioavailability. Transdermal administration displayed a variable absorption rate and possible deposition of melatonin in the skin. Oral transmucosal administration of melatonin exhibited a high plasma concentration compared to oral administration. Subcutaneous injection of melatonin displayed a rapid absorption rate compared to oral administration. Conclusion: Intranasal administration of melatonin has a large potential, and more research in humans is warranted. Transdermal application of melatonin has a possible use in a local application, due to slow absorption and deposition in the skin. Oral transmucosal administration may potentially be a clinically relevant due to avoiding first-pass metabolism. Subcutaneous injection of melatonin did not document any advantages compared to other administration routes.

AB - Background: Melatonin is traditionally administered orally but has a poor and variable bioavailability. This study aims to present an overview of studies investigating the pharmacokinetics of alternative administration routes of melatonin. Methods: A systematic literature search was performed and included experimental or clinical studies, investigating pharmacokinetics of alternative administration routes of melatonin in vivo. Alternative administration routes were defined as all administration routes except oral and intravenous. Results: 10 studies were included in the review. Intranasal administration exhibited a quick absorption rate and high bioavailability. Transdermal administration displayed a variable absorption rate and possible deposition of melatonin in the skin. Oral transmucosal administration of melatonin exhibited a high plasma concentration compared to oral administration. Subcutaneous injection of melatonin displayed a rapid absorption rate compared to oral administration. Conclusion: Intranasal administration of melatonin has a large potential, and more research in humans is warranted. Transdermal application of melatonin has a possible use in a local application, due to slow absorption and deposition in the skin. Oral transmucosal administration may potentially be a clinically relevant due to avoiding first-pass metabolism. Subcutaneous injection of melatonin did not document any advantages compared to other administration routes.

KW - bioavailability

KW - intranasal

KW - subcutaneous

KW - transdermal

KW - transmucosal

U2 - 10.1055/s-0035-1565083

DO - 10.1055/s-0035-1565083

M3 - Review

C2 - 26514093

AN - SCOPUS:84964319923

VL - 66

SP - 169

EP - 173

JO - Drug Research

JF - Drug Research

SN - 2194-9379

IS - 4

ER -

ID: 179281191